The vaccine’s mechanism also involves modulating the tumor microenvironment by reducing the number of regulatory T cells (Tregs) and increasing cytotoxic CD8+ T cells, shifting the balance toward an anti-tumor immune state [46]. The gene discussed is CD8A; the disease is neoplasm.